Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Price Up 0.8% – Here’s Why

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) shares traded up 0.8% on Wednesday . The stock traded as high as $40.36 and last traded at $40.36. 1,225 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 7,219 shares. The stock had previously closed at $40.04.

Innovator IBD Breakout Opportunities ETF Stock Up 0.8%

The stock has a market capitalization of $14.13 million, a PE ratio of 28.69 and a beta of 1.08. The business’s fifty day moving average is $38.03 and its 200-day moving average is $37.92.

Innovator IBD Breakout Opportunities ETF Dividend Announcement

The firm also recently declared an annual dividend, which was paid on Friday, January 2nd. Shareholders of record on Wednesday, December 31st were given a dividend of $0.1249 per share. This represents a yield of 34.0%. The ex-dividend date of this dividend was Wednesday, December 31st.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in BOUT. Osaic Holdings Inc. increased its stake in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after buying an additional 597 shares during the period. Comprehensive Wealth Management LLC raised its stake in shares of Innovator IBD Breakout Opportunities ETF by 60.5% in the 3rd quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock valued at $411,000 after purchasing an additional 3,976 shares in the last quarter. Finally, Susquehanna International Group LLP raised its stake in Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares in the last quarter.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.